The landscape for autoimmune therapy has reached a pivotal moment as the global value of this sector is projected to hit $2.2 billion this year. While it first gained prominence as a specialized treatment for rheumatoid arthritis, the current environment is defined by its rapid expansion into dermatology and emergency care. The broadening applications of this Janus kinase (JAK) inhibitor are...
Portuguese (Brazil) 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Tiếng Việt